StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)

Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%

Bio-Techne shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Bio-Techne's shares outstanding was 157M at Jun 30, 2026. For fiscal 2026 it was 157M, down 1.7% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is 164M in fiscal 2022.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 2026157M-1.7%
FY2025Jun 30, 2025160M-0.7%
FY2024Jun 30, 2024161M-0.7%
FY2023Jun 30, 2023162M-1.4%
FY2022Jun 30, 2022164M+1.3%
FY2021Jun 30, 2021162M+2.7%
FY2020Jun 30, 2020158M+1.3%
FY2019Jun 30, 2019156M+2.2%
FY2018Jun 30, 2018152M+1.5%
FY2017Jun 30, 2017150M+0.5%
FY2016Jun 30, 2016149M+0.3%
FY2015Jun 30, 2015149M+0.6%
FY2014Jun 30, 2014148M+0.3%
FY2013Jun 30, 2013148M-0.3%
FY2012Jun 30, 2012148M-0.4%
FY2011Jun 30, 2011149M-0.5%
FY2010Jun 30, 2010149M-1.5%
FY2009Jun 30, 2009152M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026157M+0.2%
Q3 FY2026CQ1 2026Mar 31, 2026157M-1.0%
Q2 FY2026CQ4 2025Dec 31, 2025157M-2.3%
Q1 FY2026CQ3 2025Sep 30, 2025156M-3.0%
Q4 FY2025CQ2 2025Jun 30, 2025157M-2.3%
Q3 FY2025CQ1 2025Mar 31, 2025159M-1.0%
Q2 FY2025CQ4 2024Dec 31, 2024161M+0.4%
Q1 FY2025CQ3 2024Sep 30, 2024161M-0.5%
Q4 FY2024CQ2 2024Jun 30, 2024161M-0.9%
Q3 FY2024CQ1 2024Mar 31, 2024160M-0.7%
Q2 FY2024CQ4 2023Dec 31, 2023160M-1.0%
Q1 FY2024CQ3 2023Sep 30, 2023162M-0.1%
Q4 FY2023CQ2 2023Jun 30, 2023162M-0.9%
Q3 FY2023CQ1 2023Mar 31, 2023162M-1.4%
Q2 FY2023CQ4 2022Dec 31, 2022162M-1.9%
Q1 FY2023CQ3 2022Sep 30, 2022162M-1.5%
Q4 FY2022CQ2 2022Jun 30, 2022164M-0.3%
Q3 FY2022CQ1 2022Mar 31, 2022164M+0.7%
Q2 FY2022CQ4 2021Dec 31, 2021165M+2.4%
Q1 FY2022CQ3 2021Sep 30, 2021165M+2.8%
Q4 FY2021CQ2 2021Jun 30, 2021164M+3.3%
Q3 FY2021CQ1 2021Mar 31, 2021163M+3.1%
Q2 FY2021CQ4 2020Dec 31, 2020161M+1.8%
Q1 FY2021CQ3 2020Sep 30, 2020160M+2.0%
Q4 FY2020CQ2 2020Jun 30, 2020159M+1.4%
Q3 FY2020CQ1 2020Mar 31, 2020158M+1.5%
Q2 FY2020CQ4 2019Dec 31, 2019158M+2.1%
Q1 FY2020CQ3 2019Sep 30, 2019157M+1.1%
Q4 FY2019CQ2 2019Jun 30, 2019157M+2.1%
Q3 FY2019CQ1 2019Mar 31, 2019155M+1.9%
Q2 FY2019CQ4 2018Dec 31, 2018155M+2.2%
Q1 FY2019CQ3 2018Sep 30, 2018155M+2.9%
Q4 FY2018CQ2 2018Jun 30, 2018153M+2.1%
Q3 FY2018CQ1 2018Mar 31, 2018153M+1.7%
Q2 FY2018CQ4 2017Dec 31, 2017152M+1.2%
Q1 FY2018CQ3 2017Sep 30, 2017151M+0.6%
Q4 FY2017CQ2 2017Jun 30, 2017150M–
Q3 FY2017CQ1 2017Mar 31, 2017150M–
Q2 FY2017CQ4 2016Dec 31, 2016150M–
Q1 FY2017CQ3 2016Sep 30, 2016150M–

More Bio-Techne figures

See a number that looks wrong?